BMI1
BMI1 (BMI1 proto-oncogene, polycomb ring finger) is a ring finger component of the Polycomb group PRC1-like complex, which maintains transcriptional repression of target genes during development. It is also known as RNF51 and PCGF4. Browse Assay Genie's current range of BMI1 research reagents below, or read on for the biology behind the target.
BMI1 is a component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. The PRC1 complex acts through chromatin remodelling and histone modification, and mediates monoubiquitination of histone H2A at Lys-119, leaving chromatin heritably changed in its expressibility. A complex composed of RNF2, UB2D3 and BMI1 binds nucleosomes and is active only on nucleosomal histone H2A. Within the PRC1-like complex, BMI1 regulates the E3 ubiquitin-protein ligase activity of RNF2/RING2.
The BMI1 gene encodes a ring finger protein and is classified by HGNC within the ring finger proteins and the Polycomb group ring fingers. UniProt records the protein in the nucleus and the cytoplasm. According to the NCBI Gene summary, BMI1 is a major component of PRC1, acting as an essential epigenetic repressor of multiple regulatory genes involved in embryonic development and self-renewal in somatic stem cells. The protein also plays a central role in DNA damage repair. A mouse ortholog, Bmi1, is recognised, and a pseudogene of the human gene lies on chromosome X. Read-through transcription also exists between BMI1 and the upstream COMMD3 gene.
The current name reflects the original description as B lymphoma Mo-MLV insertion region 1 homolog, and the gene has also been called polycomb group ring finger 4 (PCGF4). BMI1 is an oncogene: aberrant expression is associated with numerous cancers and with resistance to certain chemotherapies, which makes the BMI1 protein a frequent subject in cancer and stem cell research.
BMI1 is part of PRC1, which maintains repression of genes such as Hox genes through chromatin remodelling and histone H2A monoubiquitination.
The PRC1 complex containing BMI1 represses regulatory genes involved in embryonic development and self-renewal in somatic stem cells.
BMI1 is an oncogene whose aberrant expression is associated with numerous cancers, making it a focus for tumour studies.
BMI1 plays a central role in DNA damage repair, and its expression is associated with resistance to certain chemotherapies.
BMI1 is a component of a Polycomb group PRC1-like complex that keeps many genes, including Hox genes, transcriptionally repressed during development. The complex monoubiquitinates histone H2A at Lys-119, and BMI1 regulates the E3 ligase activity of RNF2/RING2 within it.
BMI1 is also known as RNF51 and PCGF4. Its HGNC name is BMI1 proto-oncogene, polycomb ring finger, and UniProt lists it as Polycomb complex protein BMI-1. Earlier names include polycomb group ring finger 4 and B lymphoma Mo-MLV insertion region 1 homolog.
BMI1 is an oncogene, and aberrant expression is associated with numerous cancers and resistance to certain chemotherapies. A mouse ortholog, Bmi1, exists; check the datasheet of any product for its validated reactivity.
Other Polycomb group proteins, PRC1 components and epigenetic regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P35226; product specifications from Assay Genie datasheets.